Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Regulatory News (ALM)

  • There is currently no data for ALM

Directorate Change

31 May 2018 07:00

RNS Number : 7163P
Allied Minds PLC
31 May 2018
 

Allied Minds appoints Fritz Foley as an Independent Non-Executive Director

 

Directorate Change

Appointment of Independent Non-Executive Director

Boston, MA (31 May 2018) - Allied Minds plc (LSE: ALM) today announces the appointment of Fritz Foley as an Independent Non-Executive Director.

Fritz Foley is the André R. Jakurski Professor and Senior Associate Dean for Strategic Financial Planning at Harvard Business School (HBS) where his research focuses on corporate finance. Prior to joining the HBS faculty in 2004, he taught at the University of Michigan Business School. He has published papers on investment, capital structure, working capital management, dividend policy, joint ventures, intellectual property, and corporate tax policy, and has advised firms in technology, biotech, retail, health care, professional services, and other industries on financial matters and strategic choices. He has also served as a trustee for several nonprofit organizations.

Peter Dolan, Chairman of Allied Minds, commented "We are delighted to welcome Fritz Foley to the Board of Allied Minds. His insights and network as a highly respected corporate finance specialist will be invaluable to the Board."

 

Fritz Foley commented "I look forward to working with the Board and leadership team at Allied Minds and applying my academic experience for the benefit of its subsidiaries as they focus on exploiting the commercial potential of US academic breakthroughs."

 

There are no further details in relation to Mr Foley's appointment which require disclosure pursuant to paragraph 9.6.13 of the Listing Rules of the Financial Conduct Authority.

Mr Foley gained his Ph. D. in Business Economics from Harvard University and his B.A. in Ethics, Politics, and Economics from Yale University.

 

 

ENDS

 

For more information, please contact:

 

Allied Minds plc

Neil Pizey, Head of Corporate Development

+1 617 419 1800

IR@alliedminds.com

FTI Consulting

Ben Atwell / Brett Pollard

+44 20 3727 1000

 

 

About Allied Minds

Allied Minds plc is an IP commercialisation company focused on technology and life sciences. With extensive access to U.S. federal government laboratories and universities, as well as partnerships with leading U.S. corporations, Allied Minds forms, funds, and operates a portfolio of companies with the objective of delivering successful liquidity events that will generate attractive long-term returns for its investors and stakeholders. Allied Minds supports its businesses with capital, resources, and expertise.

 

Allied Minds Forward-Looking Statement

This press release contains statements that are or may be forward-looking statements, including statements that relate to Allied Minds' future prospects, developments and strategies. The forward-looking statements are based on current expectations and are subject to known and unknown risks and uncertainties that could cause actual results, performance and achievements to differ materially from current expectations, including, but not limited to, those risks and uncertainties described in the risk factors included in Allied Minds' regulatory filings. These forward-looking statements are based on assumptions regarding the present and future business strategies of Allied Minds and the environment in which it will operate in the future. Each forward-looking statement speaks only as at the date of this press release. Except as required by law, regulatory requirement, the Listing Rules and the Disclosure Guidance and Transparency Rules, neither Allied Minds nor any other party intends to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAAMMJTMBMJBJP
Date   Source Headline
9th Feb 20164:35 pmRNSPrice Monitoring Extension
9th Feb 20167:00 amRNSTrading Statement
4th Feb 20163:15 pmRNSHolding(s) in Company
4th Feb 20167:00 amRNSAllied Minds Subsidiary Produces Prototype
1st Feb 20167:00 amRNSAllied Minds Subsidiary Raises $22 million
15th Jan 20167:00 amRNSDirectorate Change
11th Jan 20165:31 pmRNSHolding(s) in Company
7th Jan 20164:57 pmRNSBlocklisting Six Monthly Return
3rd Nov 20153:55 pmRNSTotal Voting Rights
28th Oct 201510:53 amRNSHolding(s) in Company
13th Oct 20154:53 pmRNSHolding(s) in Company
12th Oct 20152:58 pmRNSHolding(s) in Company
5th Oct 20157:00 amRNSPrecision Biopsy Raises $33.6 Million
23rd Sep 20157:00 amRNSFederated Wireless NASCTN first pilot test
17th Sep 20157:00 amRNSFormation of HawkEye 360
4th Sep 20154:19 pmRNSDirectorate Change
1st Sep 20157:03 amRNSAllied Minds Names Joseph Pignato as CFO
27th Aug 20157:04 amRNSHalf Yearly Report
27th Aug 20157:01 amRNSABLS Licenses Technology and Molecules from Yale
25th Aug 20154:24 pmRNSAppointment of New Senior Independent Director
31st Jul 20153:02 pmRNSTotal Voting Rights
30th Jun 20159:37 amRNSTotal Voting Rights
26th Jun 20155:16 pmRNSDirector/PDMR Shareholding
22nd Jun 20157:00 amRNSABLS licenses IP from Harvard
10th Jun 20155:06 pmRNSBlocklisting Six Monthly Return
5th Jun 20157:30 amRNSLong Term Incentive Plan
5th Jun 20157:00 amRNSAppointment of Kevin Sharer to Board of Directors
28th May 20156:06 pmRNSResult of AGM
28th May 20157:00 amRNSAGM Statement
22nd May 20154:07 pmRNSHolding(s) in Company
21st May 20152:17 pmRNSHolding(s) in Company
20th May 20157:33 amRNSResults of Placing
28th Apr 201512:00 pmRNSCapital Markets Day
28th Apr 20157:31 amRNSAnnual Results Release
28th Apr 20157:00 amRNSAppointment of New Non-Executive Chairman
22nd Apr 20157:00 amRNSSciFluor Life Sciences Raises $30 Million
2nd Apr 20153:40 pmRNSHolding(s) in Company
1st Apr 20154:33 pmRNSTotal Voting Rights
26th Mar 20152:30 pmRNSNotice of Results and Capital Markets Day
20th Mar 20154:35 pmRNSPrice Monitoring Extension
10th Mar 20157:02 amRNSAllied Minds Announces the Formation of BridgeSat
3rd Feb 20154:06 pmRNSHolding(s) in Company
8th Jan 20157:00 amRNSSciFluor Life Sciences Awarded U.S. Patent
4th Dec 20147:00 amRNSSciFluor Life Sciences Awarded U.S. Patent
19th Nov 201410:03 amRNSBlock Listing of Shares
12th Nov 20147:00 amRNSAllied Minds Appointment of Joint Broker
5th Nov 20147:00 amRNSAllied Minds Appoints Donna See as Vice President
30th Oct 20147:00 amRNSAllied Minds forms Seamless Devices, Inc.
20th Oct 20143:12 pmRNSHolding(s) in Company
9th Oct 201410:11 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.